Intracranial Hypertension Induced by Rofecoxib

$48.00 plus tax (Refund Policy)

Download / Buy Article:

Abstract:

Several secondary causes are implicated in the etiology of idiopathic intracranial hypertension. Rofecoxib is a selective cyclo-oxygenase (COX)-2 inhibitor, now being increasingly used in place of nonselective nonsteroidal anti-inflammatory drugs (NSAIDs). We report a case of intracranial hypertension in a 69-year-old man 3 weeks after the commencement of rofecoxib therapy with reversal of clinical findings on drug withdrawal.

(Headache 2005;45:75-88)

Keywords: intracranial hypertension; rofecoxib

Document Type: Research Article

DOI: http://dx.doi.org/10.1111/j.1526-4610.2005.05013.x

Publication date: January 1, 2005

Related content

Tools

Favourites

Share Content

Access Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content
Cookie Policy
X
Cookie Policy
ingentaconnect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more